期刊文献+

类风湿关节炎患者IL-17、IL-18、IL-6和TNF-α检测的意义 被引量:42

类风湿关节炎患者IL-17、IL-18、IL-6和TNF-α检测的意义
在线阅读 下载PDF
导出
摘要 目的探讨白细胞介素-17(IL-17)、白细胞介素-18(IL-18)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)在类风湿关节炎(RA)患者外周血中的表达和临床意义。方法应用ELISA方法对40例活动期RA患者、40例稳定期RA患者和40例健康对照组的外周血血清中的IL-17、IL-18、IL-6和TNF-α含量进行检测分析。结果活动期RA患者的血清中IL-17、IL-18、IL-6和TNF-α含量明显高于稳定期RA患者(P<0.01)和健康对照组(P<0.01);稳定期RA患者的血清中IL-17和IL-18含量高于健康对照组(P<0.05),而IL-6和TNF-α含量与对照组相比,差异无统计学意义(P>0.05)。结论RA患者IL-17、IL-18、IL-6和TNF-α含量的变化特点与病情相关,联合动态监测有助于临床观察和治疗。 Objective To investigate the levels of IL-17, IL-18, IL-6, and TNF-α in serum from patients with rheumatoid arthritis (RA) and its clinical significance. Methods Levels oflL-17, IL-18, IL-6, and TNF-α in 80 patients with RA and 40 normal controls (NC) were measured by ELISA. Results The levels of IL- 17, IL- 18, IL-6, and TNF-α in active RA patients were significantly higher than those in stable RA and in NC. The levels ofIL-17 and IL-18 were significantly different between stable RA and NC. There were no difference in IL-6 and TNF- α levels between the two groups. Conclusion IL-17, IL-18, IL-6 and TNF- α are more sensitive index for detecting the activity of rheumatoid arthritis and may play an important role in monitoring the therapeutic effects and prognosis of RA.
出处 《当代医学》 2010年第7期13-14,共2页 Contemporary Medicine
关键词 类风湿关节炎 白细胞介素 肿瘤坏死因子 Rheumatoid arthritis IL, Tumor necrosis factor
  • 相关文献

参考文献3

二级参考文献30

  • 1王霖,王文杰.破骨细胞在类风湿性关节炎骨破坏中的作用及其调控机制[J].生理科学进展,2004,35(3):269-272. 被引量:37
  • 2杨晓峰 郭仁.C-反应蛋白及临床应用[J].国外医学临床生物化学与临床检验学分册,1985,1:12-15.
  • 3Vuoheenaho K, Moilanen T, Hamalainen M, et al. Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage, Role of endegonous IL- 1 inhibitors [ J ]. Scand J Rheumatol, 2003,32 ( 1 ) : 19-24.
  • 4Yamamura M, Kawashima M, Taniai M, et al. Interferon-T-inducing activity of interleukin-18 in the joint rheumatoid arthritis [ J ]. Arthritis Rheum, 2001,44 ( 2 ) : 275 -285.
  • 5Leung BP,Mc Inncs IB,Esfandiari E, et al. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis[J]. J Immunol, 2000,164 ( 12 ) : 6495 -6502.
  • 6Dinarello CA. Interleukin-18 and the treatment of rheumatoid arthritis[J]. Rheum Dis Clin North Am,2004,30(2):417-434.
  • 7Park CC, Morel JC, Amin MA, et al. Evidence of IL-18 as a novel angiogenic mediator[J] .J Immunol,2001,167(3) : 1644-1653.
  • 8Moore KW,de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor [J]. Annu Rev Immunol, 2001, 19: 683-765.
  • 9Min SY, Hwang SY, Park KS, et al, Induction of IL-10-producing CD4^+ CD25^+ T cells in animal model of collagen-induced arthritis by oral administration of type Ⅱ collagen[J]. Arthritis Res Ther, 2004,6( 3 ) :R213-219.
  • 10Szekanecz Z, Haines GK, Har LA, et al. Increased synovial expression of transforming growth factor (TGF)-βreceptor endoglin and TGF-βin rheumatoid arthritis possible interactions in the pathogenesis of the desease[J] . Clin Immunol Immunopathol, 1995,7(2) : 187.

共引文献49

同被引文献380

引证文献42

二级引证文献337

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部